A Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-2)
Clinical trial NCT06456567 · WITHDRAWN
Trial details
- NCT number
- NCT06456567
- Sponsor
- Vor Biopharma
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-01
- Primary completion
- 2025-01-02
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.